ES2132217T3 - Nuevo derivado de benzopirano. - Google Patents

Nuevo derivado de benzopirano.

Info

Publication number
ES2132217T3
ES2132217T3 ES93902526T ES93902526T ES2132217T3 ES 2132217 T3 ES2132217 T3 ES 2132217T3 ES 93902526 T ES93902526 T ES 93902526T ES 93902526 T ES93902526 T ES 93902526T ES 2132217 T3 ES2132217 T3 ES 2132217T3
Authority
ES
Spain
Prior art keywords
benzopirano
new derivative
represent
hydroxy
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93902526T
Other languages
English (en)
Inventor
Hiroshi Chugai Seiyaku Ka Koga
Hiroyuki Chugai Seiyaku Nabata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2132217T3 publication Critical patent/ES2132217T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

UN DERIVADO DE BENZOPIRANO REPRESENTADO POR LA FORMULA GENERAL (I), QUE TIENE UNA FUNCION ACTIVADORA DEL CANAL K+ Y POR TANTO SE PUEDE UTILIZAR COMO ANTIASMATICO, ANTIEPILEPTICO, ETCETERA. EN LA FORMULA (I), R1 REPRESENTA HIDROGENO O HIDROXI; R2 Y R3 REPRESENTAN CADA UNO ALKILO INFERIOR, ETC.; R4 Y R5 REPRESENTAN CADA UNO HIDROGENO, HALOALKILO INFERIOR, HALOGENO, NITRO, ETC.; X REPRESENTA =O, =S, = N-CN, ETC.; E Y REPRESENTA HIDROXI, AMINO SUSTITUIDO, ETC.
ES93902526T 1992-01-24 1993-01-25 Nuevo derivado de benzopirano. Expired - Lifetime ES2132217T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1081992 1992-01-24

Publications (1)

Publication Number Publication Date
ES2132217T3 true ES2132217T3 (es) 1999-08-16

Family

ID=11760967

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93902526T Expired - Lifetime ES2132217T3 (es) 1992-01-24 1993-01-25 Nuevo derivado de benzopirano.

Country Status (15)

Country Link
US (1) US5646308A (es)
EP (1) EP0632033B1 (es)
JP (1) JP3260458B2 (es)
KR (1) KR100217167B1 (es)
CN (1) CN1036918C (es)
AT (1) ATE178601T1 (es)
AU (1) AU3367393A (es)
CA (1) CA2128603A1 (es)
DE (1) DE69324354T2 (es)
DK (1) DK0632033T3 (es)
ES (1) ES2132217T3 (es)
GR (1) GR3030581T3 (es)
SG (1) SG52734A1 (es)
WO (1) WO1993015068A1 (es)
ZA (1) ZA93436B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5428031A (en) * 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
WO1994025021A1 (en) * 1993-04-23 1994-11-10 Chugai Seiyaku Kabushiki Kaisha Benzopyran derivative
EP0677519A4 (en) * 1993-11-10 1996-04-03 Japan Tobacco Inc CHROMAN DERIVATIVE AND THERAPEUTIC USE THEREOF.
AU692300B2 (en) * 1993-11-22 1998-06-04 Merck & Co., Inc. 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1, 4-benzodiazepines
US5631251A (en) * 1995-06-07 1997-05-20 Merck & Co., Inc. 5-cyclopropyl-1,4 benzodiazepine-2-ones
US5700797A (en) * 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
US5726171A (en) * 1995-06-07 1998-03-10 Merck & Co Inc N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamides
US5691331A (en) * 1995-06-07 1997-11-25 Merck & Co., Inc. N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
EP0833819B1 (en) * 1995-06-07 2003-03-26 Merck & Co., Inc. Novel n-(2-oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
KR100343832B1 (ko) * 1996-08-27 2002-07-20 시오노기세이야쿠가부시키가이샤 크로멘-3-카르복실산 유도체
FR2756284B1 (fr) * 1996-11-26 2000-04-28 Adir Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TW533073B (en) 1997-03-03 2003-05-21 Chugai Pharmaceutical Co Ltd Therapeutic agents for peripheral vascular disease
US6218411B1 (en) * 1997-08-08 2001-04-17 Chugai Seiyaku Kabushiki Kaisha Therapeutics for diabetic complications
CN1328551A (zh) * 1998-09-30 2001-12-26 中外制药株式会社 4－取代苯并吡喃衍生物的制备方法
CZ20013076A3 (cs) * 2000-08-29 2002-04-17 Kuraray Co., Ltd. Způsob výroby chromankarboxylové kyseliny
KR100602191B1 (ko) * 2004-03-10 2006-07-19 한국화학연구원 5-라이폭시게네이즈 저해활성을 가지는2,2'-이중치환-3,4-디하이드로-7,8-이중치환-6-알킬아미노벤조피란 유도체
RU2372344C2 (ru) * 2004-05-05 2009-11-10 Ф. Хоффманн-Ля Рош Аг Арилсульфонилбензодиоксаны, применяемые для модуляции 5-нт6 рецептора, 5-нт2a рецептора или и того, и другого
EP1737847B1 (en) 2004-07-30 2008-06-04 Torrent Pharmaceuticals Ltd Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
CN101119965B (zh) * 2004-12-21 2012-09-26 弗·哈夫曼-拉罗切有限公司 萘满和茚满衍生物及其用途
CA2591793A1 (en) * 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
BRPI0515830A (pt) 2004-12-21 2008-08-05 F Hoffmann La Roche derivados de cromano e usos dos mesmos no tratamento de distúrbios do sistema nervoso central
ES2306275T3 (es) * 2004-12-21 2008-11-01 F. Hoffmann-La Roche Ag Derivados de cromano y sus usos como ligandos dde receptores 5-ht.
AU2005318598B2 (en) * 2004-12-21 2010-08-26 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof as 5-HT antagonists
KR100704009B1 (ko) * 2005-08-30 2007-04-04 한국화학연구원 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(ｎ-메틸치환술폰아미도)메틸-2ｈ-1-벤조피란 유도체
DE602006020351D1 (en) * 2005-11-03 2011-04-07 Hoffmann La Roche Arylsulfonylchromane als 5-ht6-inhibitoren
AU2007263084A1 (en) * 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
JP2009541249A (ja) * 2006-06-20 2009-11-26 エフ．ホフマン−ラ ロシュ アーゲー アリールスルホニルナフタレン誘導体およびその使用
CA2655524A1 (en) * 2006-06-20 2007-12-27 F. Hoffman-La Roche Ag Arylsulfonamidyl tetralin derivatives and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH619701A5 (es) * 1975-08-07 1980-10-15 Bayer Ag
JPS57167981A (en) * 1981-04-08 1982-10-16 Kowa Co Benzopyran derivative
GB8911280D0 (en) * 1989-05-17 1989-07-05 Beecham Group Plc Novel compounds
DE69128477T2 (de) * 1990-07-27 1998-07-16 Chugai Pharmaceutical Co Ltd Benzopyranderivat

Also Published As

Publication number Publication date
AU3367393A (en) 1993-09-01
DE69324354D1 (de) 1999-05-12
EP0632033A4 (es) 1995-02-01
ZA93436B (en) 1993-08-25
KR100217167B1 (ko) 1999-09-01
ATE178601T1 (de) 1999-04-15
WO1993015068A1 (en) 1993-08-05
EP0632033B1 (en) 1999-04-07
GR3030581T3 (en) 1999-10-29
DE69324354T2 (de) 1999-11-25
JP3260458B2 (ja) 2002-02-25
KR950700277A (ko) 1995-01-16
SG52734A1 (en) 1998-09-28
CN1077954A (zh) 1993-11-03
CN1036918C (zh) 1998-01-07
US5646308A (en) 1997-07-08
CA2128603A1 (en) 1993-08-05
JPH05294954A (ja) 1993-11-09
EP0632033A1 (en) 1995-01-04
DK0632033T3 (da) 1999-10-18

Similar Documents

Publication Publication Date Title
ES2132217T3 (es) Nuevo derivado de benzopirano.
MY138525A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
TW258735B (es)
ATE250606T1 (de) Purinderivate und ihre anwendung als anticoagulante
FR15C0027I1 (es)
ES2119017T3 (es) Derivados que contienen azufre de 2-ciano-1,3-dionas y su uso como herbicidas.
ATE174758T1 (de) Stabile flüssige zusammensetzungen und ihre verwendung
ES2111572T3 (es) Nuevo derivado de benzopirano.
NO20002834L (no) S-oksyd og S,S-dioksyd-tetrahydrothiopyran- fenyloksazolidinoner
PT947504E (pt) Derivados de vitamina d 16-eno
ES2115003T3 (es) Aminocicloalcanobenzodioxoles como agentes adrenergicos selectivos beta-3.
ES2120498T3 (es) Nuevo compuesto tetraciclico.
ATE160357T1 (de) Neues antibiotikum, deoxymulündocandin, verfahren zu seiner produktion und verwendung als medikament
DK0381989T3 (da) 4-epi-4-amino-anthracycliner
ATE100996T1 (de) Blattglanzmittel.
ES2059928T3 (es) Ciclopropanotiocarboxiamidas.
DE3785888D1 (de) 3-substituierte 1-(2-halogen-alkoxy-benzolsulfonyl)-3-heteroaryl-harnstoffe.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 632033

Country of ref document: ES